Here's What Key Metrics Tell Us About Stryker (SYK) Q1 Earnings
https://www.zacks.com/stock/news/2265491/here-s-what-key-metrics-tell-us-about-stryker-syk-q1-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm-2265491
Apr 30, 2024 - The headline numbers for Stryker (SYK) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
HAE vs. SYK: Which Stock Should Value Investors Buy Now?
https://www.zacks.com/stock/news/2192336/hae-vs-syk-which-stock-should-value-investors-buy-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2192336
Dec 01, 2023 - HAE vs. SYK: Which Stock Is the Better Value Option?
0
Top Stock Reports for Berkshire Hathaway, Mastercard & ServiceNow
https://www.zacks.com/commentary/2192786/top-stock-reports-for-berkshire-hathaway-mastercard-servicenow?cid=CS-ZC-FT-research_daily-2192786
Dec 04, 2023 - Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BRK.B), Mastercard Incorporated (MA) and ServiceNow, Inc. (NOW).
0
Reasons to Retain Stryker (SYK) Stock in Your Portfolio Now
https://www.zacks.com/stock/news/2192765/reasons-to-retain-stryker-syk-stock-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2192765
Dec 04, 2023 - Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio.
0
Stryker's (SYK) New Tech Aims to Improve Surgeon's Efficiency
https://www.zacks.com/stock/news/2210235/stryker-s-syk-new-tech-aims-to-improve-surgeon-s-efficiency?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2210235
Jan 15, 2024 - Stryker's (SYK) Blueprint Mixed Reality Guidance system aims to benefit shoulder arthroplasty surgeons by improving efficiency and minimizing errors.
0
Zimmer Biomet (ZBH) Q4 Earnings Top Estimates, Margins Grow
https://www.zacks.com/stock/news/2223473/zimmer-biomet-zbh-q4-earnings-top-estimates-margins-grow?cid=CS-ZC-FT-analyst_blog|earnings_article-2223473
Feb 08, 2024 - Each of Zimmer Biomet's (ZBH) geographic segments records strong year-over-year sales growth on a reported basis, as well as at CER in the fourth quarter.
0
Here's Why You Should Retain CVS Health (CVS) Stock for Now
https://www.zacks.com/stock/news/2226281/here-s-why-you-should-retain-cvs-health-cvs-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2226281
Feb 14, 2024 - Investors are optimistic about CVS Health (CVS) on its strong segmental performance and impressive restructuring plan.
0
Edwards (EW) Gains From Balanced Core Growth and New Launches
https://www.zacks.com/stock/news/2226830/edwards-ew-gains-from-balanced-core-growth-and-new-launches?cid=CS-ZC-FT-analyst_blog|zer_report_update-2226830
Feb 15, 2024 - Edwards (EW) is demonstrating the strong performance of the SAPIEN 3 Ultra valve in the United States, Europe and Rest of World.
0
Here's Why You Should Retain Insulet (PODD) Stock for Now
https://www.zacks.com/stock/news/2227404/here-s-why-you-should-retain-insulet-podd-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2227404
Feb 16, 2024 - The huge success of Omnipod 5 boosts investors' confidence in Insulet (PODD).
0
ResMed (RMD) to Treat Sleep Apnea With New AirCurve 11 (Revised)
https://www.zacks.com/stock/news/2227458/resmed-rmd-to-treat-sleep-apnea-with-new-aircurve-11-revised?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2227458
Feb 16, 2024 - ResMed's (RMD) new AirCurve11 series incorporates MyAir and AirView digital health apps to provide maximum comfort and support during therapy.
0